Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Opening snapshot: Stocks sell off continues...

Mon, 15th Jun 2020 08:52

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts Joice Alves (joice.alves@thomsonreuters.com) and
Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo
(stefano.rebaudo@thomsonreuters.com) in Milan.

OPENING SNAPSHOT: STOCKS SELL OFF CONTINUES... (0745 GMT)

European shares slide on fears of second wave of coronavirus cases with Beijing reporting
new infections.

The pan-European index fell 2.5% with basic resources and travel
leading the losses down almost 4%.

In terms of single stocks, BP is down 5% after it said it will incur an up to $17.5 billion
writedown in the value of its assets.

But on a positive note, Bunzl jumped 8.5% as it forecast an increase in revenue for the
first half of the year, while shares at biopharmaceutical company Ucb jumped 10%.

(Joice Alves)

*****

ON THE RADAR: SENSIRION, EASYJET, ASTRAZENECA and M&A (0645 GMT)

The disconnect between market sentiment and corporate news flow continues with futures
pointing to a start of the week in the red for European bourses as investors fear a second wave
of infections. Meantime, some companies prepare to return to work or engage in M&A deals.

EasyJet resumes flying for the first time since March 30 with COVID-19 measures in place and
Volkswagen will begin sending workers back to plant in Mexico on Tuesday.

Swiss sensor maker Sensirion lifts 2020 outlook as sales skyrocketed on COVID-19 demand
spike for ventilator sensors, while H&M's March-May sales tumble 50%, slightly less than
expected.

AstraZeneca signed a contract with European governments to supply the region with its
potential vaccine against the coronavirus.

In the M&A world, Cineworld scraps deal to buy Cineplex; while Metro Bank is in exclusive
talks to buy peer-to-peer lender RateSetter and Italy's BPER Banca approved a revised deal with
Intesa Sanpaolo to address antitrust issues in Intesa's takeover bid for UBI Banca.

Germany says coronavirus tracing smartphone app ready to go. Deutsche Telekom and software
company SAP are involved in the project.

BP will incur an up to $17.5 billion writedown in the value of its assets after lowering its
long-term oil and gas price outlook in expectation of an accelerated transition away from fossil
fuels. The company said that the coronavirus pandemic will accelerate the pace of transition to
a lower-carbon economy.

(Joice Alves)

*****

MORNING CALL: FEARS OF SECOND WAVES (0545 GMT)

Futures are pointing to a start of the week in the red for European bourses as risk appetite
gets a hit by fears of a second wave of COVID-19 infections after Beijing recorded new
infections in recent days.

Dozens of new cases all linked to a major wholesale food market were enough to encourage
investors to seek for safe-heavens across the world as authorities in China locked down housing
districts near the market.

News flow in Europe could help to improve the mood as countries are easing border controls
and the UK opens its shops.

Global coronavirus cases have crossed 7.86 million with 430,501? deaths, according to a
Reuters tally.

(Joice Alves)

*****

More News
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more
14 Nov 2023 09:22

AstraZeneca's latest lung cancer trial fails its primary endpoint

(Sharecast News) - AstraZeneca announced on Tuesday that its 'PACIFIC-2' phase three trial for Imfinzi, or durvalumab, concurrently administered with chemoradiotherapy (CRT), did not achieve its primary endpoint of progression-free survival compared to CRT alone.

Read more
13 Nov 2023 09:45

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Nov 2023 15:02

London close: Stocks gain as investors await Powell speech

(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.

Read more
9 Nov 2023 12:06

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data.

Read more
9 Nov 2023 11:02

Lancashire Holdings declares special dividend after strong year so far

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date.

Read more
9 Nov 2023 09:23

TOP NEWS: AstraZeneca ups guidance; inks licence deal for obesity drug

(Alliance News) - AstraZeneca PLC on Thursday announced that it signed a contract for an obesity drug as it reported a higher pretax profit in the third quarter of 2023, boosted by cancer drug conjugate Enhertu.

Read more
9 Nov 2023 08:57

LONDON MARKET OPEN: FTSE 100 kicks off day with cautious gain

(Alliance News) - London's FTSE 100 struggled for direction early Thursday, with a mixed slate of corporate updates, US interest rate worries and underwhelming China data preventing it from making more confident progress in early trade.

Read more
9 Nov 2023 07:48

LONDON BRIEFING: AstraZeneca ups outlook but S4 Capital cuts

(Alliance News) - London's FTSE 100 is set for another downbeat start to the day, with more hawkish comments from US central bankers and tepid data out of China doing little to lift the mood.

Read more
9 Nov 2023 07:18

AstraZeneca hikes guidance after strong third quarter

(Sharecast News) - AstraZeneca released its financial results for the third quarter and first nine months of 2023 on Thursday, hiking its full-year guidance on the back of a robust performance and momentum in several segments.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.